How it works
How Much Does Chemotherapy for breast cancer Cost in Republic of Korea?
Chemotherapy for breast cancer in the Republic of Korea typically costs from $3,000 to $13,000. Total expenses depend on the drug protocols, cancer stage, and chosen medical facility. Patients save approximately 82% compared to the US, where the average cost is $45,000. Quotes generally include oncologist consultations, blood tests, and basic supportive medications for international patients.
- Hospital tier: Prices in Seoul clinics like Samsung Medical Center are often higher than regional centers.
- Drug type: Targeted therapies or immunotherapies typically add a significant premium over standard cytotoxic drugs.
- Session frequency: Total costs scale based on the number of cycles required for the treatment.
- Ancillary services: Costs for PET-CT scans and MRIs are usually billed separately from the chemotherapy cycles.
Bookimed Expert Insight: Choosing a specialized facility provides exceptional value through advanced technology. Ewha Womans University Medical Center is a dedicated women-only hospital with a 5-star rating. It focuses on aesthetic outcomes and minimally invasive techniques. Highly ranked institutions like Asan Medical Center use AI and digital imaging to improve safety. These top-tier Seoul hospitals are consistently recognized in Newsweek's World's Best Hospitals rankings.
| Republic of Korea | Turkey | Austria | |
|---|---|---|---|
| Chemotherapy for breast cancer | from $3,000 | from $4,700 | ≈ $9,500 |
Discover the Best Chemotherapy for breast cancer Clinics in Republic of Korea: 9 Verified Options and Prices
Ewha Womans University Medical Center
Paik Nam-sun






Chemotherapy for breast cancer Overview in Republic of Korea
- Chemotherapy - from $1,900This therapy treats cancer by using drugs to destroy cancer cells and prevent their growth.
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - from $18,000The operation heats chemotherapy drugs and applies them directly inside the belly to kill hidden cancer cells.
- Chemotherapy for liver cancer - from $3,000This therapy targets and kills cancer cells in the liver, using drugs given by mouth or injection.
- Chemotherapy for lung cancer - from $1,500This therapy utilizes drugs to kill lung cancer cells, often given via injection or oral tablet, enhancing survival rates.
- Chemotherapy for breast cancer - from $3,000This therapy targets and destroys breast cancer cells, using powerful drugs, enhancing survival and recovery rates.
Day 1: Arrival
- Arrive in the country and check into the hotel.
- Rest and acclimate to the new environment.
Day 2: Pre-Operation
- Undergo initial consultation with the oncologist.
- Have a full medical check-up.
- Take an audiometry test for hearing baseline.
- Additional tests if needed, based on your health condition.
Day 3: Chemotherapy
- Admitted to the hospital for chemotherapy treatment.
- Undergo Chemotherapy which usually lasts for a few hours.
- No anesthesia is required as the process is painless.
- Post-treatment, rest at the hospital under medical supervision.
Day 4: Post-Operation
- Consultation with oncologist to discuss the treatment effects.
- Stay at the hospital for continued monitoring and care.
Day 5: Departure
- Discharge from the hospital and transfer to the hotel.
- Rest and recovery at the hotel before travelling back.
Week 1-4: Rehabilitation
- Regular follow-ups with your local oncologist.
- Gradual return to work and other activities as strength allows.
- Engage in mild physical exercises under guidance.
- Noticeable improvement in health and decrease in treatment side-effects.
Week 8: Final Result
- Complete recovery and return to normal lifestyle.
Please note that the process may vary based on individual health condition and response to the treatment.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Doctors
View all Doctors
Kim Wan Song
Dr. Wan‑Sung Kim, MD, PhD, is Director of the Thyroid Center and an Associate Professor of Surgery at Myongji Hospital, an educational partner of Hanyang University. He is a breast and thyroid surgeon. He treats cancer and benign disease and focuses on minimally invasive thyroid and adrenal surgery.
Expertise: endoscopic and robotic thyroidectomy (transoral, axillary-areolar), thyroid radiofrequency ablation, ethanol ablation for thyroid lesions, and endoscopic or robotic adrenal tumor surgery.
He previously served as Head of Surgery at Myongji Hospital and Chuncheon Gangnam Hospital. He completed his residency and a breast and thyroid fellowship at Myongji. He holds an MD and MS from Catholic Kwandong University and a PhD from Kangwon National University. He is a member of the Korean Association of Thyroid and Endocrine Surgeons, the Korean Breast Cancer Society, the Korean Surgical Society, and the Korean Surgical Ultrasound Society.

Kim Tae Joong
Dr. Kim Tae Joong specializes in gynecologic oncology at Samsung Medical Center, focusing on breast cancer treatment.
- Oncogynecologist with a focus on chemotherapy for breast cancer
- Works at Samsung Medical Center, a leading institution in cancer care
- Dedicated to providing personalized treatment plans

Cho Jae-Yong
Dr. Cho Jae-Yong is an oncologist specializing in breast cancer treatment at Severance Hospital.
- Focuses on chemotherapy for breast cancer patients
- Works at Severance Hospital, a leading medical institution
- Dedicated to providing personalized treatment plans

Cho Byung Chul
Head of the Oncology Department at Severance Hospital – Dr. Cho Byung Chul specializes in chemotherapy for breast cancer.
- Experienced in chemotherapy for various cancers including breast, lung, and esophageal cancer
- Works with new clinical drugs for targeted therapies
- Specializes in treating complex cases requiring advanced chemotherapy protocols
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
Fast Facts about Chemotherapy for breast cancer

Chemotherapy for breast cancer
Chemotherapy for breast cancer is a systemic treatment using drugs to destroy cancer cells in the body.
FAQ about Chemotherapy for breast cancer in Republic of Korea
What are the standard chemotherapy regimens used in South Korea for breast cancer?
Standard breast cancer chemotherapy in South Korea follows NCCN and ESMO international guidelines adapted by the Korean Breast Cancer Society. Common regimens include anthracycline-based AC, taxane-sequential protocols like AC-T, and targeted HER2 therapies such as TCH, often administered at JCI-accredited centers in Seoul.
- Early-stage protocol: TC (Docetaxel and Cyclophosphamide) for 4 cycles is standard for HER2-negative cases.
- HER2-positive treatment: TCH-P (Docetaxel, Carboplatin, Herceptin, and Perjeta) is commonly used at major hospitals.
- Triple-negative therapy: Neoadjuvant Pembrolizumab combined with Paclitaxel and Carboplatin follows the KEYNOTE-522 protocol.
- Metastatic HR+ care: CDK4/6 inhibitors like Palbociclib or Ribociclib are standard first-line treatments.
Bookimed Expert Insight: South Korean oncology centers like Samsung Medical Center and Asan Medical Center leverage high patient volumes to refine dose-dense schedules. National protocols often utilize GnRH agonists early for the country's younger patient demographic to protect ovarian function during intensive chemotherapy cycles.
Patient Consensus: Patients report that major Korean hospitals emphasize genomic testing like Oncotype DX upfront to determine if chemotherapy can be safely skipped. The use of domestic generics and aggressive supportive care helps minimize physical downtime during treatment.
Which hospitals in Korea are top-rated for breast-cancer chemotherapy?
Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital are the top-rated facilities for breast cancer chemotherapy in Korea. These institutions consistently rank in the global top 10 for oncology. They utilize precision medicine, multidisciplinary tumor boards, and advanced molecular targeted therapies to treat complex cases.
- Samsung Medical Center: Ranked 3rd globally, it utilizes precision medicine and molecular targeted drugs.
- Asan Medical Center: Ranked 5th globally, its breast center reports 95% 5-year survival rates.
- Seoul National University Hospital: Leads in personalized genetic care and processes over 2,200 annual surgeries.
- Ewha Womans University: Specialized women-only facility focusing on aesthetic-preserving treatments and minimal scarring.
Bookimed Expert Insight: While rankings highlight clinical power, the choice between Seoul's `Big Five` often comes down to sub-specialization. For example, Ewha Womans University Medical Center is uniquely optimized for female patients, prioritizing aesthetic outcomes alongside oncology. Bookimed data shows it maintains a perfect 5-star rating despite serving a smaller, more focused patient volume.
Patient Consensus: Individuals value the advanced protocols and significantly shorter wait times in Korea compared to Western systems. Many emphasize that researching an oncologist's specific tumor board practices is more helpful than following general hospital rankings.
What side-effects do Korean patients most often report during breast-cancer chemotherapy?
Korean patients undergoing breast cancer chemotherapy most frequently report fatigue, nausea, and hair loss as their primary side effects. Intense physical symptoms often stem from aggressive high-dose protocols used in Seoul centers like Samsung Medical Center, leading to unique hematological concerns such as higher neutropenia rates compared to Western populations.
- Physical fatigue: Affects up to 89% of patients as the most common systemic symptom.
- Gastrointestinal distress: Nausea and vomiting impact 79% of patients during high-dose AC-T cycles.
- Complete alopecia: Hair loss occurs in up to 93% of cases by week 3.
- Hematological toxicity: Neutropenia and anemia are prevalent, with anemia affecting 67% of patients.
- Neurological symptoms: Peripheral neuropathy, including numbness in hands and feet, affects 47% of patients.
Bookimed Expert Insight: While many Western clinics prioritize comfort, top Korean facilities like Severance Hospital often utilize shorter, higher-dose chemotherapy protocols to maximize efficacy. This aggressive approach explains why patients report intense nausea but also contributes to the high survival rates seen at flagship institutions like Seoul National University Hospital. Patients should ask for duloxetine early to manage the neuropathy that often follows these specific Korean drug regimens.
Patient Consensus: Patients emphasize that nausea during AC-T cycles is significantly more intense than expected and advise proactively shaving hair by the second week to manage the emotional trauma of rapid alopecia. Ginger tea and traditional porridges are frequently cited as the most effective remedies for the metallic taste and mouth sores that interfere with a standard Korean diet.
Are there any Korea-specific guidelines or unique treatment options for breast-cancer chemotherapy?
South Korea adapts breast cancer chemotherapy for a younger patient demographic through unique guidelines from the Korean Breast Cancer Society. Treatments often feature compressed two-week cycles and integrated Korean medicine. High-precision care at centers like Samsung Medical Center includes frequent PET monitoring and proactive fertility preservation.
- Regional guidelines: Clinical practice guidelines standardize care specifically for Asian biological responses and toxicities.
- Compressed timelines: Patients often receive chemotherapy every 2 weeks instead of 3-week cycles.
- Integrated medicine: Centers routinely combine acupuncture and herbal protocols to manage chemotherapy side effects.
- Aggressive monitoring: Protocols include monthly PET scans and weekly blood work during active treatment.
Bookimed Expert Insight: While many global centers prioritize surgery first, South Korean oncologists at top-tier facilities like Ewha Womans University Medical Center significantly favor neoadjuvant chemotherapy. This aggressive approach aims to shrink tumors before surgery, often utilizing advanced immunotherapy combinations and CDK4/6 inhibitors that reach Korean clinics faster through active clinical trial hubs.
Patient Consensus: Patients report that oncologists are highly directive and provide standardized nutritional support, including mandatory dietitian consultations. Many find the integration of fertility preservation and traditional immune support creates a more holistic recovery experience.






















